iDEL Therapeutics is a cancer therapeutics company.
iDEL Therapeutics has raised $10.4M in total funding. The most recent round was Seed. The last funding was announced in March 2026.
iDEL Therapeutics's investors include BioMedPartners, Gruenderfonds Ruhr, KHAN Technology Transfer Fund, NRW.Venture.
iDEL Therapeutics is headquartered in Dortmund, Germany.
iDEL Therapeutics is a cancer therapeutics company.
iDEL Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"iDEL Therapeutics — Funding & Investors." VCBacked, March 17, 2026, https://www.vcbacked.co/company/idel-therapeutics. Accessed August 1, 2026.
VCBacked. (2026). iDEL Therapeutics — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/idel-therapeutics
{{cite web |title=iDEL Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/idel-therapeutics |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated